Q-omics provides the consensus-scored MIR519B profile across patient tissues and cancer cell-line models. MIR519B expression is associated with patient survival in 8 of 34 cancer types, with the highest sampling consensus in ACC. Additionally, MIR519B RNA expression shows 6,430 significant pathway-activity associations, with the highest sampling consensus in STAD. Together, these results highlight ACC, and STAD as cancer lineages where MIR519B shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.